Global /Indonesia /Healthcare /Drug Manufacturers - General /DVLA
chevron_leftBack
PT Darya-Varia Laboratoria Tbk logo

PT Darya-Varia Laboratoria Tbk

DVLA
IDX: DVLA Delayed
1,605.00IDR 0%
0.0897 USD
As of 10 June 2026, PT Darya-Varia Laboratoria Tbk has a market cap of $100.44M USD, ranking #25610 globally and #382 in Indonesia. It ranks #2292 in the Healthcare sector, and #830 in the Drug Manufacturers - General industry.
Global Rank
25610
Country Rank
382
Sector Rank
2292
Industry Rank
830
Key Stats
Market Cap
$100.44MUSD
1.8T IDR
Enterprise Value
$77.71MUSD
1.39T IDR
Revenue (TTM)
$118.63MUSD
2.12T IDR
EBITDA (TTM)
$16.34MUSD
292.42B IDR
Net Income (TTM)
$9.67MUSD
173.09B IDR
EBITDA Margin
14%
Profit Margin
8.2%
PE Ratio
10.4
PS Ratio
0.8
PB Ratio
1.2
EV/EBITDA
4.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ian Martin Kloer open_in_new
Employees
1,311
Founded
1976
Website
darya-varia.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -0.6% -0.6% -3.3% -6.5% -5.1%

News

Loading...

Markets

Exchange Ticker Price
Indonesia Stock Exchange
MIC: XIDX
PRIMARY
DVLA
ISIN: ID1000117203
Shares Out.:
1.12B1 Shares Float: 88.263M2
TV:
SA:
YF:
GF:
BA:
MS:
1,605.00 IDR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About PT Darya-Varia Laboratoria Tbk

PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. It also provides Consumer Health products comprising Skin Nutrition under the Natur-E brand; Respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brand names for nasal congestion, cough, as well as breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; and supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. In addition, the company offers toll manufacturing services for soft gelatin capsules, and sterile injections and low volume solid products. It also exports its products. PT Darya-Varia Laboratoria Tbk was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.

Similar Companies

Industry: Drug Manufacturers - General (Indonesia)
Name
Market Cap diff.
PE
KLBF
$2.21B
39.63T IDR
2K%
10.9
$1.37B
24.43T IDR
1K%
40.7
$203.43M
3.64T IDR
103%
-
KAEF
$149.3M
2.67T IDR
49%
-
MERK
$107.64M
1.93T IDR
7.2%
7.9
$19.2M
343.67B IDR
-81%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
758K%
38.1
JNJ
$547.28B
545K%
26.4
ABBV
$360.63B
359K%
97.4
$321.16B
256.25B CHF
320K%
19.9
AZN
$288.62B
215.59B GBP
287K%
27.6
NOVN
$274.35B
218.9B CHF
273K%
20.5
chevron_leftBack